Royal Bank of Canada’s PROSENSA HLDGS N V ORD SHS (NLD) RNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q4
Sell
-17,750
Closed -$149K 6519
2014
Q3
$149K Buy
17,750
+4,100
+30% +$38.9K ﹤0.01% 4390
2014
Q2
$172K Sell
13,650
-8,350
-38% -$67.8K ﹤0.01% 4269
2014
Q1
$124K Buy
22,000
+12,000
+120% +$74.4K ﹤0.01% 4428
2013
Q4
$47K Buy
+10,000
New +$45.6K ﹤0.01% 4924

Other funds holding RNA

Royal Bank of Canada's RNA Position: Q4 2014 in Review

Royal Bank of Canada sold out of PROSENSA HLDGS N V ORD SHS (NLD) (RNA) in Q4 2014, closing a stake of 17,750 shares — an estimated $149K sold.

Royal Bank of Canada first reported a position in RNA in Q4 2013 and held it in 4 quarters. The position peaked at $172K in Q2 2014. 47 funds tracked by Wall St. Rank hold RNA as of Q4 2014.

  • Royal Bank of Canada reported no remaining PROSENSA HLDGS N V ORD SHS (NLD) position as of Q4 2014 after selling out during the quarter.
  • Royal Bank of Canada sold 17,750 PROSENSA HLDGS N V ORD SHS (NLD) shares in Q4 2014, an estimated $149K.
  • Royal Bank of Canada first reported a position in PROSENSA HLDGS N V ORD SHS (NLD) in Q4 2013 and held it in 4 quarters.
  • Royal Bank of Canada's PROSENSA HLDGS N V ORD SHS (NLD) position peaked at $172K in Q2 2014.
  • 47 funds tracked by Wall St. Rank held PROSENSA HLDGS N V ORD SHS (NLD) as of Q4 2014.

Based on Royal Bank of Canada's 13F filing for Q4 2014, filed 17 Feb 2015.